Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV)-Reference-Cited by-同舟云学术

Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV)

Published:2016-06 Issue: Volume:176 Page:83-92
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Puri Rishi,Nissen Steven E.,Somaratne Ransi,Cho Leslie,Kastelein John J.P.,Ballantyne Christie M.,Koenig Wolfgang,Anderson Todd J.,Yang Jingyuan,Kassahun Helina,Wasserman Scott M.,Scott Robert,Borgman Marilyn,Nicholls Stephen J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference62 articles.

1. Lipoproteins, cardiovascular disease, and death. The Framingham Study;Gordon;Arch Intern Med,1981

2. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization;Aikawa;Circulation,1998

3. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study;Voight;Lancet,2012

4. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis;Ference;J Am Coll Cardiol,2012

5. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring?;Current Atherosclerosis Reports;2024-08-16

2. Coronary atherosclerotic plaque regression strategies;The Journal of Biomedical Research;2024

3. PCSK9 inhibitors for acute coronary syndrome: the era of early implementation;Frontiers in Cardiovascular Medicine;2023-05-02

4. Genetics, Safety, Cost-Effectiveness, and Accessibility of Injectable Lipid-Lowering Agents: A Narrative Review;Journal of Lipids;2023-03-08

5. High density lipoprotein as a therapeutic target: Focus on its functionality;BIOCELL;2023